A Phase 2 Randomized Controlled Multisite Study Using Omalizumab-facilitated Rapid Desensitization to Test Continued vs Discontinued Dosing in Multifood Allergic Individuals

BACKGROUND: As there is limited data on the sustainability of desensitization of multifood-oral immunotherapy (multifood-OIT), we conducted a multisite multifood-OIT study to compare the efficacy of successful desensitization with sustained dosing vs discontinued dosing after multifood-OIT. METHODS:...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:EClinicalMedicine
Main Authors: Andorf, Sandra, Purington, Natasha, Kumar, Divya, Long, Andrew, O'Laughlin, Katherine L., Sicherer, Scott, Sampson, Hugh, Cianferoni, Antonella, Whitehorn, Terri Brown, Petroni, Daniel, Makhija, Melanie, Robison, Rachel G., Lierl, Michelle, Logsdon, Stephanie, Desai, Manisha, Galli, Stephen J., Rael, Efren, Assa'ad, Amal, Chinthrajah, Sharon, Pongracic, Jacqueline, Spergel, Jonathan M., Tam, Jonathan, Tilles, Stephen, Wang, Julie, Nadeau, Kari
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2019
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6537534/
https://ncbi.nlm.nih.gov/pubmed/31193674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2018.12.006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados